Identification of Long Non-Coding RNA as Potential Biomarkers for the Diagnosis of Postmenopausal Osteoporosis
Conclusion: The lncRNA ZNF529 is significantly overexpressed in PBMC in PMOP, and bioinformatics analysis and validation experiments indicate that it is closely associated with PMOP; thus, it is expected to be a potential diagnostic marker for PMOP.
Saved in:
| Main Authors: | Zhu Yihua, Peng Chenjian, Wang Lining, Jiang Shujun, Yang Haomiao, Zhang Kaixuan, Dai Fenglei, Ma Yong, Chu Xudong, Zhang Chunlei, Sun Haitao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-01-01
|
| Series: | International Journal of Endocrinology |
| Online Access: | http://dx.doi.org/10.1155/2024/8820697 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fosavance™ for postmenopausal osteoporosis
by: Editorial Office
Published: (2008-06-01) -
Plasma serotonin precursors and metabolites as diagnostic and therapeutic biomarkers for osteoporosis in postmenopausal women
by: Peiying Li, et al.
Published: (2025-06-01) -
Identification and validation of TUBB, CLTA, and FBXL5 as potential diagnostic markers of postmenopausal osteoporosis
by: Yue Tan, et al.
Published: (2025-08-01) -
RISK ASSESSMENT FOR OSTEOPOROSIS IN POSTMENOPAUSAL WOMEN
by: Z. Shukerova
Published: (2020-12-01) -
Association between lncRNA H19 and osteoporosis in postmenopausal patients with type 2 diabetes mellitus
by: Teng Yang, et al.
Published: (2025-08-01)